Peter Kiener
2016
In 2016, Peter Kiener earned a total compensation of $1.5M as Chief Science Officer at Sucampo Pharmaceuticals, a 10% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $272,949 |
|---|---|
| Option Awards | $847,550 |
| Salary | $414,721 |
| Other | $12,000 |
| Total | $1,547,221 |
Kiener received $847.6K in option awards, accounting for 55% of the total pay in 2016.
Kiener also received $272.9K in non-equity incentive plan, $414.7K in salary and $12K in other compensation.
Rankings
In 2016, Peter Kiener's compensation ranked 6,096th out of 14,075 executives tracked by ExecPay. In other words, Kiener earned more than 56.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,096 out of 14,075 | 57th |
Division Manufacturing | 2,223 out of 5,489 | 60th |
Major group Chemicals And Allied Products | 728 out of 1,895 | 62nd |
Industry group Drugs | 550 out of 1,538 | 64th |
Industry Pharmaceutical Preparations | 430 out of 1,176 | 63rd |
Source: SEC filing on April 21, 2017.
Kiener's colleagues
We found four more compensation records of executives who worked with Peter Kiener at Sucampo Pharmaceuticals in 2016.
2016
Peter Greenleaf
Sucampo Pharmaceuticals
Chief Executive Officer
2016
Max Donley
Sucampo Pharmaceuticals
EVP, Global Human Resources, Information Technology and Strategy
2016
Matthias Alder
Sucampo Pharmaceuticals
General Counsel
2016
Andrew Smith
Sucampo Pharmaceuticals